A comprehensive view of Initial Public Offering (IPO). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Executive Perspective: Cava's IPO last June was 'not a destination, it was just another step in our journey,' says CFO Tricia Tolivar, adding that going public required extensive preparation over the course of about 18-24 months

Galderma prices IPO at CHF 53/share and will start trading on the SIX Swiss Exchange tomorrow

Indorama Ventures to separate, list its surfactants business--the downstream part of its Integrated Oxides and Derivatives business--via IPO; it will be named Indovinya and listed in US, while upstream part will transfer to Combined PET segment: ICIS

Indorama Ventures intends to separate and list its packaging unit through an IPO; business generates PET preforms bottles and closures, has grown almost 11%-12%/year in past three to five years, would be listed in Asia: ICIS

Galderma Launches IPO on the SIX Swiss Exchange and Sets Price Range

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count